Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs

European Respiratory Journal

Volumn 13, Issue 5, 1999, Pages 1037-1043

  Hohlfeld, J M ^a   Struber M ^a   Ahlf, K ^a   Hoeper, M M ^a   Fraund, S ^a   Krug, N ^a   Warnecke, G ^a   Harringer, W ^a   Haverich, A ^a   Fabel, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Exogenous surfactant treatment; Lung transplantation; Pulmonary surfactant; Reperfusion injury; Surfactant dysfunction

Indexed keywords

LUNG SURFACTANT;

ANIMAL MODEL; ARTICLE; BREATHING MECHANICS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INTRABRONCHIAL DRUG ADMINISTRATION; LUNG HEMODYNAMICS; LUNG INJURY; LUNG LAVAGE; LUNG TRANSPLANTATION; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; REPERFUSION INJURY; SURFACE PROPERTY; SURVIVAL; SWINE;

ANIMALS; FEMALE; LIPIDS; LUNG; LUNG TRANSPLANTATION; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; REPERFUSION INJURY; RESPIRATORY MECHANICS; SWINE; SWINE, MINIATURE;

EID: 0345620866     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13e17.x     Document Type: Article

References (36)

1. Davis RDJ, Pasque MK. Pulmonary transplantation. Ann Surg 1995; 221: 14-28.
2. Iversen S. Surgical treatment of thromboembolism-induced pulmonary hypertension. Z Kardiol 1994; 83: 193-199.
3. Novick RJ, Menkis AH, McKenzie FN. New trends in lung preservation: a collective review. J Heart Lung Transplant 1992; 11: 377-392.
4. Klepetko W, Lohninger A, Wisser W, et al. Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of L-carnitine application. J Thorac Cardiovasc Surg 1990; 99: 1048-1058.
5. Veldhuizen RA, Lee J, Sandler D, et al. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 1993; 148: 208-215.
6. Erasmus ME, Peterson AH, Oetomo SB, Prop J. The function of surfactant is impaired during the reimplantation response in rat lung transplants. J Heart Lung Transplant 1994; 13: 791-802.
7. Andrade RS, Solien EE, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RMI. Surfactant dysfunction in lung preservation. Transplantation 1995; 60: 536-541.
8. Hamm H, Kroegel C, Hohlfeld J. Surfactant: a review of its functions and relevance in adult respiratory disorders. Respir Med 1996; 90: 251-270.
9. Seeger W, Stohr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 1985; 58: 326-338.
10. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987; 62: 429-437.
11. Seeger W, Grube C, Günther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6: 971-977.
12. Bredenberg CE, Paskanik AM, Nieman GF. High surface tension pulmonary oedema. J Surg Res 1983; 34: 515-523.
13. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B. Inactivation of exogenous surfactant by pulmonary oedema fluid. Pediatr Res 1991; 29: 353-356.
14. Holm BA, Kelcher L, Liu M, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991; 71: 317-321.
15. Pison U, Tam EK, Caughey GH, Hawgood S. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 1989; 992: 251-257.
16. Lewis RW, Harwood JL, Tetley TD, Harris E, Richards RJ. Degradation of human and rat surfactant apoprotein by neutrophil elastase and cathepsin G. Biochem Soc Trans 1993; 21: 206S.
17. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-1981.
18. Günther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung oedema. Am J Respir Crit Care Med 1996; 153: 176-184.
19. Walmrath D, Günther A, Ghofrani HA, et al. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996; 154: 57-62.
20. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 1309-1315.
21. Novick RJ, Veldhuizen RAW, Possmayer F, Lee J, Sandler D, Lewis JF. Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation. J Thorac Cardiovasc Surg 1994; 108: 259-268.
22. Erasmus ME, Petersen AH, Hofstede G, Haagsman HP, Bambang-Oetomo S, Prop J. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 1996; 153: 665-670.
23. Novick RJ, MacDonald J, Veldhuizen RAW, et al. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 1996; 154: 98-104.
24. Hausen B, Rohde R, Hewitt CW, et al. Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 1997; 113: 1050-1058.
25. Struber M, Cremer J, Harringer W, Hirt SW, Costard-Jackle A, Haverich A. Nebulized synthetic surfactant in reperfusion injury after single lung transplantation. J Thorac Cardiovasc Surg 1995; 110: 563-564.
26. Institute of Laboratory Animal Resources National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Washington DC, National Academy Press, 1996.
27. Haverich A, Aziz S, Scott WC, Jamieson SW, Shrumway NE. Improved lung preservation using Euro-Collins solution for flush-perfusion. Thorac Cardiovasc Surg 1986; 34: 368-376.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
29. Barlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959; 234: 466-468.
30. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
31. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43: 198-203.
32. Rosner BA. Fundamentals in Biostatistics. 4th Edn. Belmont, CA, Duxberry Press, 1995.
33. Buchanan SA, Mauncy MC, Parekh VI, et al. Intratracheal surfactant administration preserves airway compliance during lung reperfusion. Ann Thorac Surg 1996; 62: 1617-1621.
34. Blau H, Rikhs S, Van Iwaarden JF, McCormack FX, Kalina M. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. Am J Physiol 1997; 272: L1198-L1204.
35. Miles PR, Bowmann L, Rengasamy A, Huffman L. Alveolar type II cell cNOS activity and ATP levels are increased by lung surfactant or DPPC vesicles. Am J Physiol 1997; 273: L339-L346.
36. Bacha EA, Herve P, Murakami S, et al. Lasting beneficial effect of short term inhaled nitric oxide on graft function after lung transplantation. J Thorac Cardiovasc Surg 1996; 112: 590-598.